AVID BIOSERVICES INC. - COMMON STOCK

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023

21 6 2023 16:07:37 提供 Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2023 After Market Close on June 21, 2023

14 6 2023 16:05:54 提供 Nasdaq GlobeNewswire

Avid Bioservices to Participate in RBC Capital Markets Global Healthcare Conference

10 5 2023 16:05:31 提供 Nasdaq GlobeNewswire

Avid Bioservices Unveils Completed Mammalian Cell Facilities Expansion Providing Significantly Increased Capacity for Existing and Future Customers

04 4 2023 08:05:38 提供 Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent Developments

13 3 2023 16:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2023 After Market Close on March 13, 2023

06 3 2023 16:05:56 提供 Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2022 and Recent Developments

06 12 2022 16:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 After Market Close on December 6, 2022

29 11 2022 16:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices Appoints Oksana Lukash as Vice President, People

16 11 2022 08:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference

02 11 2022 16:05:01 提供 Nasdaq GlobeNewswire

Avid Bioservices to Participate in RBC Global CDMO Conference

27 9 2022 16:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices Appoints Michael Alston, Jr. as Vice President, Operations

22 9 2022 08:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare Conference

07 9 2022 16:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent Developments

06 9 2022 16:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices Appoints Pramthesh (Prem) Patel, Ph.D., as Vice President, Process Development for Mammalian Cell Business

01 9 2022 08:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2023 After Market Close on September 6, 2022

30 8 2022 16:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Fourth Quarter and Full Fiscal Year Ended April 30, 2022 and Recent Developments

29 6 2022 16:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2022 After Market Close on June 29, 2022

22 6 2022 16:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices Announces Launch of Analytical and Process Development Suites Within New, World-Class Viral Vector Development and Manufacturing Facility

14 6 2022 08:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business

13 6 2022 08:05:00 提供 Nasdaq GlobeNewswire